Hypoxia-induced dedifferentiation of tumor cells -: A mechanism behind heterogeneity and aggressiveness of solid tumors

被引:233
作者
Axelson, H
Fredlund, E
Ovenberger, M
Landberg, G
Påhlman, S
机构
[1] Lund Univ, Dept Lab Med, Div Mol Med, Univ Hosp Mas, SE-20502 Malmo, Sweden
[2] Lund Univ, Dept Lab Med, Div Pathol, Malmo, Sweden
关键词
hypoxia; differentiation; neuroblastoma; sympathetic nervous system; breast carcinoma; HIF-1; alpha; HIF-2;
D O I
10.1016/j.semcdb.2005.03.007
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Histopathological examination of solid tumors frequently reveals pronounced tumor cell heterogeneity with regards to cell organization, cell morphology, cell size, nuclei morphology, etc. Analyses of gene expression patterns by immunohistochemistry or in situ hybridization techniques further strengthen the actual presence of phenotypic heterogeneity, often demonstrating substantial diversity within a given tumor. The molecular mechanisms underlying the phenotypic heterogeneity are very complex with genetic, epigenetic and environmental components. Hypoxia, shortage in oxygen, greatly influences cellular phenotypes by altering the expression of specific genes, and is an important contributor to intra- and inter-tumor cell diversity as revealed by the pronounced but non-uniform expression of hypoxia driven genes in solid tumors (reviewed in [Semenza GL. Targeting HIF-1 for cancer therapy. Nat Rev Cancer 2003;3:721-32; Harris AL. Hypoxia - a key regulatory factor in tumour growth. Nat Rev Cancer 2002;2:38-47.]). The oxygen pressure in solid tumors is generally lower than in the surrounding non-malignant tissues, and tumors exhibiting extensive hypoxia have been shown to be more aggressive than corresponding tumors that are better oxygenized [Vaupel P. Oxygen transport in tumors: characteristics and clinical implications. Adv Exp Med Biol 1996;388:341-51; Vaupel P, Thews 0, Hoeckel M. Treatment resistance of solid tumors: role of hypoxia and anemia. Med Oncol 2001; 18:243-59.]. We recently observed that hypoxic neuroblastoma cells and breast cancer cells loose their differentiated gene expression patterns and develop stem cell-like phenotypes [Jogi A, Ora I, Nilsson H, Lindeheim A, Makino Y, Poellinger L, et a]. Hypoxia alters gene expression in human neuroblastoma cells toward an immature and neural crest-like phenotype. Proc Natl Acad Sci USA 2002;99:7021-6; Helczynska K, Kronblad A, Jogi A, Nilsson E, Beckman S, Landberg G, et al. Hypoxia promotes a dedifferentiated phenotype in ductal breast carcinoma in situ. Cancer Res 2003;63:1441-4.]. As low stage of differentiation in neuroblastoma and in breast cancer is linked to poor prognosis, hypoxia-induced dedifferentiation will not only contribute to tumor heterogeneity but could also be one mechanism behind increased aggressiveness of hypoxic tumors. The effect(s) of hypoxia on tumor cell differentiation status is the focus of this review. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:554 / 563
页数:10
相关论文
共 57 条
[1]   GLUT-1 and CAIX as intrinsic markers of hypoxia in carcinoma of the cervix: Relationship to pimonidazole binding [J].
Airley, RE ;
Loncaster, J ;
Raleigh, JA ;
Harris, AL ;
Davidson, SE ;
Hunter, RD ;
West, CML ;
Stratford, IJ .
INTERNATIONAL JOURNAL OF CANCER, 2003, 104 (01) :85-91
[2]   Molecular characterization of the tumor microenvironment in breast cancer [J].
Allinen, M ;
Beroukhim, R ;
Cai, L ;
Brennan, C ;
Lahti-Domenici, J ;
Huang, HY ;
Porter, D ;
Hu, M ;
Chin, L ;
Richardson, A ;
Schnitt, S ;
Sellers, WR ;
Polyak, K .
CANCER CELL, 2004, 6 (01) :17-32
[3]  
Alsat E, 1996, J CELL PHYSIOL, V168, P346, DOI 10.1002/(SICI)1097-4652(199608)168:2<346::AID-JCP13>3.0.CO
[4]  
2-1
[5]  
Azuma Y, 2003, CLIN CANCER RES, V9, P4944
[6]   On the association of succinate dehydrogenase mutations with hereditary paraganglioma [J].
Baysal, BE .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2003, 14 (10) :453-459
[7]  
CARNAHAN JF, 1991, J NEUROSCI, V11, P3520
[8]   Reactive oxygen species generated at mitochondrial complex III stabilize hypoxia-inducible factor-1α during hypoxia -: A mechanism of O2 sensing [J].
Chandel, NS ;
McClintock, DS ;
Feliciano, CE ;
Wood, TM ;
Melendez, JA ;
Rodriguez, AM ;
Schumacker, PT .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) :25130-25138
[9]  
COUPLAND R, 1980, DEV FATE CATECOLAMIN
[10]  
Cushing H, 1927, AM J PATHOL, V3, P203